Sample | Title | Value | Rank |
GSM958322 | U87-EV human glioblastoma xenograft - Control - 1 [HG-U133_Plus_2] | 3.6418 | 58 |
GSM958323 | U87-EV human glioblastoma xenograft - Control - 2 [HG-U133_Plus_2] | 3.47003 | 56 |
GSM958324 | U87-EV human glioblastoma xenograft - Control - 3 [HG-U133_Plus_2] | 3.6841 | 58 |
GSM958328 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 1 [HG-U133_Plus_2] | 3.80896 | 58 |
GSM958329 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 2 [HG-U133_Plus_2] | 3.75436 | 58 |
GSM958330 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 3 [HG-U133_Plus_2] | 4.49481 | 62 |
GSM958325 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 1 [HG-U133_Plus_2] | 3.91898 | 59 |
GSM958326 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 2 [HG-U133_Plus_2] | 3.70221 | 58 |
GSM958327 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 3 [HG-U133_Plus_2] | 3.60329 | 57 |